Masthead-Image-Right-min

14 Day Rule Regarding ADLT, MolPath Tests Continues to Show Movement

Impact on CMS reimbursement of ADLTs and Molecular Pathology testing during the 14 days following a hospital stay.

Continue Reading...

Prior Authorization – The Lab’s Dilemma

Are payers’ Prior Authorization programs impacting your laboratory’s bottom line?

Continue Reading...

Three Ways Providers Can Prepare for MBI Impact

Commencing January 1, 2020, Providers must submit claims to Medicare with the Medicare Beneficiary Identifier (MBI) regardless of the date of service.

Continue Reading...

OPPS 2018 Revisions:  Outpatient 14-Day Rule Changes to Lab DOS Policy

The new CMS OPPS rule changes could impact your lab's revenue cycle process. 

Continue Reading...

Is Your Lab Aware of CMS Claim Requirements for “Unlisted” Test Codes?

Is your laboratory’s claims and reimbursement processing ready to handle CMS changes?

Continue Reading...